Cardiac rhythm abnormalities during intravenous immunoglobulin G(IVIG) infusion in two newborn infants: coincidence or association?
Authors:
Open Access
- 23 July 2015
- journal article
- Published by Wiley in Clinical Case Reports
- Vol. 3 (9) , 731-734
Abstract
Key Clinical Message We report the occurrence of supraventricular tachycardia during intravenous immunoglobulin (IVIG) infusion. Supraventricular tachycardia was observed in two newborn patients during IVIG infusion. Both of the babies responded to adenosine treatment. Cardiorespiratory monitoring during IVIG infusion can be recommended because of the possibility of this potentially lifethreatening adverse effect.Keywords
This publication has 12 references indexed in Scilit:
- Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective studyAsia Pacific Allergy, 2013
- Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.2013
- Adverse Effects of Human Immunoglobulin TherapyTransfusion Medicine Reviews, 2013
- Intravenous immunoglobulin: Adverse reactions and managementJournal of Allergy and Clinical Immunology, 2008
- Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJournal of Allergy and Clinical Immunology, 2006
- Risks associated with the use of intravenous immunoglobulin 1 1This review article reflects the opinions of the authors and not necessarily those of the U.S. Food and Drug Administration.Transfusion Medicine Reviews, 2003
- Cardiac Rhythm Abnormalities During Intravenous Immunoglobulin G Infusion for Treatment of ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1997
- Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk FactorsAnnals of Internal Medicine, 1994
- Hemolysis after high-dose intravenous Ig.1993
- A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpuraThe Journal of Pediatrics, 1993